Danone Amends Lifeway Foods Stake Filing

Ticker: LWAY · Form: SC 13D/A · Filed: Nov 15, 2024 · CIK: 814586

Sentiment: neutral

Topics: ownership-change, sec-filing, amendment

Related Tickers: LWAY

TL;DR

Danone filed an update on its Lifeway Foods holdings - watch this space.

AI Summary

Danone S.A. has filed an amendment (No. 5) to its Schedule 13D concerning Lifeway Foods, Inc. as of November 15, 2024. The filing indicates a change in beneficial ownership, with Danone North America PBC, a subsidiary of Danone S.A., being a key entity involved. The specific details of the change in ownership percentage or dollar amounts are not explicitly stated in this excerpt, but the filing signifies an ongoing relationship or transaction between Danone and Lifeway Foods.

Why It Matters

This filing indicates a potential shift in control or significant influence over Lifeway Foods by Danone, a major global food company, which could impact Lifeway's strategic direction and market position.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can signal significant corporate actions, mergers, or shifts in strategic alliances, carrying inherent investment risk.

Key Players & Entities

FAQ

What specific change in beneficial ownership is reported in this amendment?

This excerpt does not specify the exact change in beneficial ownership percentage or dollar amounts, only that it is an amendment to a Schedule 13D filed by Danone S.A. concerning Lifeway Foods, Inc.

What is the relationship between Danone S.A. and Danone North America PBC?

Danone North America PBC is identified as a subsidiary of Danone S.A. in the filing.

What is the CUSIP number for Lifeway Foods, Inc. common stock?

The CUSIP number for Lifeway Foods, Inc. common stock is 531914109.

Who is authorized to receive notices and communications for Danone S.A. regarding this filing?

Samantha Loh at Danone S.A., 17 boulevard Haussmann, 75009 Paris, France, is authorized to receive notices and communications.

What is the filing date of this Schedule 13D/A amendment?

The filing date of this Schedule 13D/A amendment is November 15, 2024.

Filing Stats: 1,498 words · 6 min read · ~5 pages · Grade level 14 · Accepted 2024-11-15 08:53:57

Key Financial Figures

Filing Documents

of the Original Schedule 13D is hereby amended and supplemented to add the following

Item 4 of the Original Schedule 13D is hereby amended and supplemented to add the following: As reported on Amendment No. 4. to the Original Schedule 13D, on September 23, 2024, Danone North America PBC sent a letter to the Issuer (the Initial Proposal ), proposing to acquire all of the outstanding shares of Common Stock not currently held by the Reporting Persons for a purchase price of $25.00 per share, paid in cash (the Proposed Transaction ). On November 5, 2024, the Issuer issued a press release announcing that the Issuer rejected the Initial Proposal and that the Issuer had adopted a shareholder rights plan in response to the Initial Proposal. On November 15, 2024, Danone North America PBC sent a second letter to the Issuer (the Updated Proposal ) in order to express its disappointment in the Boards response to the Initial Proposal and reiterate Danone North America PBCs strong commitment to the Proposed Transaction. In the Updated Proposal, Danone North America PBC increased the offer for the Proposed Transaction from $25.00 per share to $27.00 per share. The Proposed Transaction would be wholly funded in cash from existing cash reserves of the Reporting Persons and is not contingent on any financing requirements. The proposal is subject to the completion of due diligence and negotiation of definitive agreements. The foregoing summary of the Updated Proposal is not intended to be complete and is qualified in its entirety by reference to the full text of the Updated Proposal, which is filed herewith as Exhibit 99.1 and is incorporated herein by reference. No assurances can be given that the Proposed Transaction will be consummated. No legally binding obligation with respect to the Proposed Transaction will arise unless and until the relevant parties enter into mutually acceptable definitive documentation. This Schedule 13D is not an offer to purchase or a solicitation of an offer to sell any securities. The Reporting Persons intend to engage in discu

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing